{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:27:13Z","timestamp":1788017233751,"version":"build-2784847793"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The aim of this study was to investigate the hemorrhgic sites and collateral vessels in hemorrhagic MMD with the p.R4810K variant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Hemorrhage sites were classified as either anterior or posterior. Collateral vessels were classified into three subtypes according to origin: lenticulostriate anastomosis, thalamic anastomosis, and choroidal anastomosis. Hemorrhage sites and collateral vessels were compared between patients with wild-type p.R4810K variant (GG) and patients with heterozygous p.R4810K variant (GA) after 1:1 propensity score matching.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 130 hemorrhagic MMD patients were included in present study, 21 pairs (42 hemorrhagic hemispheres) were obtained after 1:1 propensity score. In GA group, 16 hemispheres (76.2%) presented anterior hemorrhage, and 5 hemispheres (23.8%) presented with posterior hemorrhage. In GG group, 13 hemispheres (61.9%) presented anterior hemorrhage, and 8 hemispheres (38.1%) presented with posterior hemorrhage. No significant differences were found in hemorrhagic sites between two matched groups (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05). Of 21 hemispheres in GA group, 10 (47.6%) exhibited lenticulostriate anastomosis, 6 (28.6%) thalamic anastomosis, and 6 (28.6%) choroidal anastomosis. Of 21 hemispheres in GG group, 3 (14.3%) exhibited lenticulostriate anastomosis, 5 (23.8%) thalamic anastomosis, and 9 (42.9%) choroidal anastomosis. There was significant difference in lenticulostriate anastomosis between two matched groups (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.045). After adjustment the age, sex, and PCA involvement, we found that lenticulostriate anastomosis was associated with p.R4810K variant (OR, 5.995; 95% CI, 1.296\u201327.737;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.022).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Lenticulostriate anastomosis might be associated with p.R4810K variant. Whereas hemorrhagic sites, thalamic anastomosis, and choroidal anastomosis might not be associted withp.R4810K variant.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-020-01884-0","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T04:03:59Z","timestamp":1597809839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Different subtypes of collateral vessels in hemorrhagic moyamoya disease with p.R4810K variant"],"prefix":"10.1186","volume":"20","author":[{"given":"Peicong","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,19]]},"reference":[{"issue":"12","key":"1884_CR1","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","volume":"360","author":"RM Scott","year":"2009","unstructured":"Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226\u201337.","journal-title":"N Engl J Med"},{"issue":"3","key":"1884_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"J Suzuki","year":"1969","unstructured":"Suzuki J, Takaku A. Cerebrovascular \u201cmoyamoya\u201d disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20(3):288\u201399.","journal-title":"Arch Neurol"},{"issue":"2","key":"1884_CR3","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3171\/2014.10.JNS132369","volume":"122","author":"XJ Liu","year":"2015","unstructured":"Liu XJ, Zhang D, Wang S, Zhao YL, Teo M, Wang R, Cao Y, Ye X, Kang S, Zhao JZ. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China. J Neurosurg. 2015;122(2):392\u20139.","journal-title":"J Neurosurg"},{"issue":"CN_suppl_1","key":"1884_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/neuros\/nyy114","volume":"65","author":"X Deng","year":"2018","unstructured":"Deng X, Ge P, Wang S, Zhang D, Zhang Y, Wang R, Zhao J. Treatment of Moyamoya Disease. Neurosurgery. 2018;65(CN_suppl_1):62\u20135.","journal-title":"Neurosurgery."},{"issue":"1","key":"1884_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5853\/jos.2015.01627","volume":"18","author":"JS Kim","year":"2016","unstructured":"Kim JS. Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke. 2016;18(1):2\u201311.","journal-title":"J Stroke."},{"issue":"5","key":"1884_CR6","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1161\/STROKEAHA.118.022771","volume":"50","author":"S Kang","year":"2019","unstructured":"Kang S, Liu X, Zhang D, Wang R, Zhang Y, Zhang Q, Yang W, Zhao JZ. Natural course of Moyamoya disease in patients with prior hemorrhagic stroke. Stroke. 2019;50(5):1060\u20136.","journal-title":"Stroke."},{"issue":"1","key":"1884_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/STROKEAHA.115.010819","volume":"47","author":"JC Takahashi","year":"2016","unstructured":"Takahashi JC, Funaki T, Houkin K, Inoue T, Ogasawara K, Nakagawara J, Kuroda S, Yamada K, Miyamoto S, JAM trial investigators. Significance of the hemorrhagic site for recurrent bleeding: Prespecified analysis in the Japan adult Moyamoya trial. Stroke. 2016;47(1):37\u201343.","journal-title":"Stroke."},{"issue":"3","key":"1884_CR8","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3171\/2016.11.JNS161650","volume":"128","author":"T Funaki","year":"2018","unstructured":"Funaki T, Takahashi JC, Houkin K, Kuroda S, Takeuchi S, Fujimura M, Tomata Y, Miyamoto S. Angiographic features of hemorrhagic moyamoya disease with high recurrence risk: a supplementary analysis of the Japan adult Moyamoya trial. J Neurosurg. 2018;128(3):777\u201384.","journal-title":"J Neurosurg"},{"issue":"2","key":"1884_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5853\/jos.2014.16.2.65","volume":"16","author":"M Fujimura","year":"2014","unstructured":"Fujimura M, Sonobe S, Nishijima Y, Niizuma K, Sakata H, Kure S, Tominaga T. Genetics and biomarkers of Moyamoya disease: significance of RNF213 as a susceptibility gene. J Stroke. 2014;16(2):65\u201372.","journal-title":"J Stroke"},{"issue":"1","key":"1884_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, Kanno J, Niihori T, Ono M, Ishii N, Owada Y, Fujimura M, Mashimo Y, Suzuki Y, Hata A, Tsuchiya S, Tominaga T, Matsubara Y, Kure S. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011;56(1):34\u201340.","journal-title":"J Hum Genet"},{"issue":"7","key":"1884_CR11","doi-asserted-by":"publisher","first-page":"e22542","DOI":"10.1371\/journal.pone.0022542","volume":"6","author":"W Liu","year":"2011","unstructured":"Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, Kikuta K, Takagi Y, Harada KH, Fujiyama A, Herzig R, Krischek B, Zou L, Kim JE, Kitakaze M, Miyamoto S, Nagata K, Hashimoto N, Koizumi A. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One. 2011;6(7):e22542.","journal-title":"PLoS One"},{"issue":"11","key":"1884_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1212\/WNL.0b013e318249f71f","volume":"78","author":"S Miyatake","year":"2012","unstructured":"Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, Tsurusaki Y, Doi H, Sakai H, Saitsu H, Shimojima K, Yamamoto T, Higurashi M, Kawahara N, Kawauchi H, Nagasaka K, Okamoto N, Mori T, Koyano S, Kuroiwa Y, Taguri M, Morita S, Matsubara Y, Kure S, Matsumoto N. Homozygous c.14576G>a variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology. 2012;78(11):803\u201310.","journal-title":"Neurology."},{"key":"1884_CR13","doi-asserted-by":"crossref","unstructured":"Ge P, Zhang Q, Ye X, Liu X, Deng X, Wang J, Wang R, Zhang Y, Zhang D, Zhao J. Angiographic characteristics in Moyamoya disease with the p.R4810K variant: a propensity score-matched analysis. Eur J Neurol. 2020;27(5):856\u201363.","DOI":"10.1111\/ene.14184"},{"issue":"1\u20132","key":"1884_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000503250","volume":"48","author":"P Ge","year":"2019","unstructured":"Ge P, Ye X, Liu X, Deng X, Wang J, Wang R, Zhang Y, Zhang D, Zhang Q, Zhao J. Association between p.R4810K variant and postoperative collateral formation in patients with Moyamoya disease. Cerebrovasc Dis. 2019;48(1\u20132):77\u201384.","journal-title":"Cerebrovasc Dis"},{"issue":"5","key":"1884_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2176\/nmc.52.245","volume":"52","author":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases","year":"2012","unstructured":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo). 2012;52(5):245\u201366.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"4","key":"1884_CR16","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3171\/2016.2.JNS152173","volume":"126","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Liu Y, Zhang D, Wang R, Zhang Y, Wang S, Yu L, Lu C, Liu F, Zhou J, Zhang X, Zhao J. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance. J Neurosurg. 2017;126(4):1106\u201313.","journal-title":"J Neurosurg"},{"issue":"8","key":"1884_CR17","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.04.013","volume":"27","author":"Y Wang","year":"2018","unstructured":"Wang Y, Mambiya M, Li Q, Yang L, Jia H, Han Y, Liu W. RNF213 p.R4810K polymorphism and the risk of Moyamoya disease, intracranial major artery stenosis\/occlusion, and quasi-Moyamoya disease: a meta-analysis. J Stroke Cerebrovasc Dis. 2018;27(8):2259\u201370.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"1884_CR18","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3171\/2015.4.JNS142900","volume":"124","author":"EH Kim","year":"2016","unstructured":"Kim EH, Yum MS, Ra YS, Park JB, Ahn JS, Kim GH, Goo HW, Ko TS, Yoo HW. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. J Neurosurg. 2016;124(5):1221\u20137.","journal-title":"J Neurosurg"},{"key":"1884_CR19","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3389\/fneur.2019.00662","volume":"10","author":"P Ge","year":"2019","unstructured":"Ge P, Ye X, Liu X, Deng X, Wang R, Zhang Y, Zhang D, Zhang Q, Zhao J. Association Between p.R4810K Variant and Long-Term Clinical Outcome in Patients With Moyamoya Disease. Front Neurol. 2019;10:662.","journal-title":"Front Neurol"},{"issue":"3\u20134","key":"1884_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1159\/000499699","volume":"47","author":"S Nomura","year":"2019","unstructured":"Nomura S, Yamaguchi K, Akagawa H, Kawashima A, Moteki Y, Ishikawa T, Aihara Y, Saito T, Okada Y, Kawamata T. Genotype-phenotype correlation in long-term cohort of Japanese patients with Moyamoya disease. Cerebrovasc Dis. 2019;47(3\u20134):105\u201311.","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"1884_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12883-020-1612-z","volume":"20","author":"P Ge","year":"2020","unstructured":"Ge P, Zhang Q, Ye X, Liu X, Deng X, Wang J, Wang R, Zhang Y, Zhang D, Zhao J. Postoperative collateral formation after indirect bypass for hemorrhagic moyamoya disease. BMC Neurol. 2020;20(1):28.","journal-title":"BMC Neurol"},{"issue":"1","key":"1884_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1161\/01.STR.0000047120.67507.0D","volume":"34","author":"M Morioka","year":"2003","unstructured":"Morioka M, Hamada J, Kawano T, Todaka T, Yano S, Kai Y, Ushio Y. Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult moyamoya patients. Stroke. 2003;34(1):90\u20135.","journal-title":"Stroke."},{"issue":"2","key":"1884_CR23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3171\/2018.10.JNS181139","volume":"132","author":"T Funaki","year":"2019","unstructured":"Funaki T, Takahashi JC, Houkin K, Kuroda S, Fujimura M, Tomata Y, Miyamoto S. Effect of choroidal collateral vessels on de novo hemorrhage in moyamoya disease: analysis of nonhemorrhagic hemispheres in the Japan adult Moyamoya trial. J Neurosurg. 2019;132(2):408\u201314.","journal-title":"J Neurosurg"},{"key":"1884_CR24","doi-asserted-by":"crossref","unstructured":"Funaki T, Takahashi JC, Houkin K, Kuroda S, Takeuchi S, Fujimura M, Tomata Y, Miyamoto S. High rebleeding risk associated with choroidal collateral vessels in hemorrhagic moyamoya disease: analysis of a nonsurgical cohort in the Japan Adult Moyamoya Trial. J Neurosurg. 2019; 130(2):337\u2013673.","DOI":"10.3171\/2017.9.JNS17576"},{"key":"1884_CR25","doi-asserted-by":"crossref","unstructured":"Fujimura M, Funaki T, Houkin K, Takahashi JC, Kuroda S, Tomata Y, Tominaga T, Miyamoto S. Intrinsic development of choroidal and thalamic collaterals in hemorrhagic-onset moyamoya disease: case-control study of the Japan Adult Moyamoya Trial. J Neurosurg. 2019;130(5):1453\u201359.","DOI":"10.3171\/2017.11.JNS171990"},{"issue":"5","key":"1884_CR26","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1161\/STROKEAHA.113.004386","volume":"45","author":"S Miyamoto","year":"2014","unstructured":"Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, Nakagawara J, Takahashi JC, JAM trial investigators. Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan adult Moyamoya trial. Stroke. 2014;45(5):1415\u201321.","journal-title":"Stroke."},{"key":"1884_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.wneu.2019.04.066","volume":"127","author":"T Sasagasako","year":"2019","unstructured":"Sasagasako T, Funaki T, Tanji M, Arakawa Y, Suzuki H, Miyakoshi A, Miyamoto S. Intractable medial anastomotic branches from the Lenticulostriate artery causing recurrent hemorrhages in Moyamoya disease. World Neurosurg. 2019;127:279\u201383.","journal-title":"World Neurosurg"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01884-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-020-01884-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01884-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T19:30:42Z","timestamp":1629315042000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-020-01884-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,19]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1884"],"URL":"https:\/\/doi.org\/10.1186\/s12883-020-01884-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-29130\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,19]]},"assertion":[{"value":"12 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by Beijing Tiantan Hospital Ethics Committee, Capital medical university. Informed consent was written obtained when patients were admitted to Department of Neurosurgery.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"308"}}